Ificipro 500 mg Tablet

Valsts: Malaizija

Valoda: angļu

Klimata pārmaiņas: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Aktīvā sastāvdaļa:

Ciprofloxacin Hydrochloride USP

Pieejams no:

UNIMED SDN BHD

SNN (starptautisko nepatentēto nosaukumu):

Ciprofloxacin Hydrochloride USP

Vienības iepakojumā:

100Tablet Tablets

Ražojis:

Unique Pharmaceuticals Laboratories (A Division Of J.B. Chemicals & Pharmaceuticals Ltd) (INDIA)

Lietošanas instrukcija

_CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP)_
IFICIPRO 250/500
Ciprofloxacin Hydrochloride Tablet USP (250mg and 500mg)
Fexofenadine Hydrochloride Tablets USP 180mg
1
WHAT IS IN THIS LEAFLET
1.
What
IFICIPRO
is used for
2.
How
IFICIPRO
works
3.
Before you use
IFICIPRO
4.
How to use
IFICIPRO
5.
While you are using it
6.
Side effects
7.
Storage
and
Disposal
of
IFICIPRO
8.
Product Description
9.
Manufacturer
and
Product
Registration Holder
10.
Date of revision
WHAT IFICIPRO IS USED FOR
IFICIPRO
can
be
used
to
treat
or
prevent
certain
infections
caused
by
bacteria: Infections of the respiratory
tract, urinary tract, gastrointestinal (GI),
skin and soft tissues, bones and joints.
Bacteria
in
the
blood
(Septicemia),
inflammation of the inner wall of the
abdomen
(peritonitis),
infection
in
patients with reduced immunity.
HOW IFICIPRO WORKS
Ificipro contains ciprofloxacin as active
ingredient. It
belongs
to
a
group
of
antibiotics called fluoroquinolone.
Antibiotics kill the bacteria or germ
which causes infections.
BEFORE YOU USE IFICIPRO
_When you must not use it _
Do not take IFICIPRO if you:
Ever had a history of hypersensitivity to
ciprofloxacin,
any
member
of
the
quinolone class of antimicrobial agents,
or any of the product components.
-
_Before you start to use it _
•
Tell your healthcare providers if you
have
been
diagnosed
with
an
enlargement or “bulge” of a large
blood
vessel
(aortic
aneurysm
or
large vessel peripheral aneurysm)
•
Tell your healthcare providers if you
have experienced a previous episode
of aortic dissection (a tear in the aorta
wall)
•
Tell your healthcare providers if you
have
a
family
history
of
aortic
aneurysm
or
aortic
dissection
or
other
risk
factors
or
predisposing
conditions
(e.g.,
connective
tissue
disorders such as Marfan syndrome,
or vascular Ehlers-Danlos syndrome,
or
vascular
disorders
such
as
Takayasu arteritis, giant cell arteritis,
Behcet’s
disease,
high
blood
pressure, or known atherosclerosis.
•
You should not take fluoroquinolone
antibacterial
medicines,
incl

Produkta apraksts

140 mm
220 mm
Front
For the use of Medical Practitioner or a Hospital or a Laboratory only
IFICIPRO* 250/500
Ciprofloxacin Tablets USP 250 mg/500 mg
COMPOSITION:
Each film coated tablet contains:
Ciprofloxacin Hydrochloride USP eq. to Ciprofloxacin 250mg / 500 mg.
DESCRIPTION:
lficipro 250mg tablets (Ciprofloxacin Tablets 250mg):
White to yellowish white, round biconvex, film coated tablets.
lficipro 500mg tablets (Ciprofloxacin Tablets 500mg):
White to yellowish white, capsule shaped film coated tablets with
break line
on one side and other side plain.
PHARMACODYNAMICS:
Ciprofloxacin is from the quinolone group; these substances are also
known
as gyrase inhibitors.
MICROBIOLOGY:
GRAM-NEGATIVE ORGANISMS
Enterobacteriaceae including
_E.coli, Salmonella _
species
_, Klebsiella _
species
_, Shigel-_
_la, Proteus mirabilis, Proteus vulgaris, K. oxytoca, Yersinia
enterocolitica, Entero-_
_bacter, Citrobacter, Morganella morganii, Pseudomonas aeruginosa,
Hemophilus _
_Influenza, Acinetobacter, Campylobacter, Brucella melitensis,
Pasteurella multo-_
_cida, Eikenella corrodenus, Flavobacterium, Moraxella, Gardenerella
Vaginalis, _
_Legionells _
species
_, Vibrio cholerae _
and
_Vibrio parahernolyticus, Neisseria menin-_
_gitidis _
and
_Neisseria gonorrhea _
including b-lactomase producing strains.
GRAM-POSITIVE ORGANISMS
_Staphylococcus aureus _
including
_ b-lactamase _
producing and
_ methicillin-resistant _
_strains, streptococcus pneumoniae group A 8-hemolytic streptococci, _
group B
_ _
_streptococci _
and other
_ streptococci, Enterococci including Enterococcus faecalis, _
_Corynebacterium _
and
_Listeria monocytogenes._
OTHER MICROORGANISMS
Anaerobic bacteria including
_actinomyces, Bifidobacterium, Peptococcus, _
_Clostridium perfringens, Eubacterium, Propioribactirium acres_
,
_Veiiionella_
and
some strains of
_Baderoides, Chlamydia, Mycoplasma and Mycobacterium_
. Ificip-
ro is effective against organisms resistant to nalidixic acid. Since
cross-resistance
is unlikely, Ificipro may be used to treat infections c